Your session is about to expire
← Back to Search
Overdose Education for Opioid Overdose
N/A
Waitlist Available
Led By Deborah Weidner, MD, MBA
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This trial studies the effectiveness of educational materials in helping opioid users fill naloxone prescriptions to reverse overdose effects. Participants get written or video education & are supported by family/friends before leaving hospital.
Who is the study for?
This trial is for patients leaving Hartford Hospital's Emergency Department with a prescription for naloxone after opioid intoxication or poisoning, including those who use illicit or prescription opioids, or have conditions related to opioid injection.Check my eligibility
What is being tested?
The study aims to see if different types of overdose education can increase the rate at which people fill their naloxone prescriptions. Participants will get either standard written instructions via MyChart or a one-page handout and video explanation before they leave the hospital.See study design
What are the potential side effects?
Since this trial focuses on educational methods rather than medications, there are no direct side effects from the interventions being tested.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Prescription fill rate
Secondary outcome measures
Education content survey
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Overdose Education (EOE)Experimental Treatment1 Intervention
A one-page education pamphlet handed to participants and their identified support individual and a 4-minute video clip that will be viewed in the hospital and emailed or texted to both. EOE is purposefully brief and intended to increase uptake by participants and their support network who may not be motivated or willing to engage in face-to-face or extensive education. The pamphlet and video both emphasize the Why and How. That is, the significance of naloxone in decreasing the likelihood of death following an overdose while providing simple instructions on how to use the nasal kit. They also emphasize an important point missing in standard education: to tell others in the support network where it is and how to use it.
Group II: Standard educationActive Control1 Intervention
Written instructions and information communicated to the patient through MyChart. The following four key points are covered: (1) When someone overdoses on opiates, their breathing will get very slow and may stop (2) Naloxone is a safe life-saving medication that can reverse an opioid overdose (3) You give someone naloxone by injecting it through the nostril, (4) If a first dose of naloxone does not work after about 3 minutes, give a second dose.
Find a Location
Who is running the clinical trial?
Hartford HospitalLead Sponsor
133 Previous Clinical Trials
18,846 Total Patients Enrolled
Hartford HealthCareOTHER
8 Previous Clinical Trials
1,200 Total Patients Enrolled
Deborah Weidner, MD, MBAPrincipal InvestigatorHartford HealthCare
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been trained on using a naloxone kit or am allergic to naloxone.I am being discharged from the hospital with a naloxone kit after an opioid-related incident.
Research Study Groups:
This trial has the following groups:- Group 1: Standard education
- Group 2: Enhanced Overdose Education (EOE)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are adults of a certain age being considered for participation in this experiment?
"Eligible participants are between 21 and 65 years of age."
Answered by AI
Do I qualify to be a research subject in this experiment?
"This medical research requires the participation of 84 individuals between 21 and 65 years old who have experienced an opioid overdose."
Answered by AI
Does this investigation need any additional participants?
"Based on data provided by clinicaltrials.gov, this medical research is not accepting new participants at the present moment. It was initially posted on July 3rd 2023 and had its last update in May 17th 2023. Despite that fact, there are still 27 other trials actively looking for patients as we speak."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger